The US Federal Trade Commission (FTC) has sued to block GTCR’s proposed $627m merger-acquisition of critical medical device ...
Axios on MSN3h
FTC sues to block medical device coatings dealThe Federal Trade Commission under President Trump is making its first move to challenge private equity in health care, by ...
The Federal Trade Commission on March 6 sued to block GTCR’ s acquisition of Surmodics, alleging that “the deal, which seeks to combine the two largest manufacturers of critical medical device ...
The FTC has blocked GTCR's $627M acquisition of SRDX, citing anti-competitive concerns. Surmodics has responded to the challenge and plans to fight the decision in court.
The regulator says the proposed merger would give the combined company more than 50% of the market for a type of medical ...
The FTC said merging Surmodics with Biocoat, where GTCR has a majority stake, would result in one company with more than 50% ...
Gallagher, which in December agreed to buy AssuredPartners from private-equity firms GTCR and Apax Partners, said it is actively responding to FTC request, and that it now expects to complete the ...
Surmodics stock drops 4.76% in premarket trading following news that the FTC will challenge its proposed acquisition by GTCR.
Lake Street analyst Brooks O’Neil upgraded Surmodics (SRDX) to Buy from Hold with an unchanged price target of $43. The Federal Trade ...
The U.S. Federal Trade Commission (FTC) has sued to block the planned acquisition of medical device company Surmodics (Nasdaq ...
The U.S. Federal Trade Commission (FTC) has filed a lawsuit to prevent medical device coatings maker Surmodics from merging ...
Surmodics, Inc. (Nasdaq: SRDX), a provider of medical device and in vitro diagnostic technologies to the healthcare industry, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback